We're sorry but our site requires JavaScript.

The SUPPRELIN® LA SHARES Program

Eligible patients can save up to $2,000 off each SUPPRELIN® LA prescription after a $10 copay

Restrictions apply*

To begin the reimbursement process
  • Ask your child's healthcare professional to complete the Service Request Enrollment Form (SRE) and the Patient Authorization Form (PAF) if necessary
  • The HCP should submit both completed forms to the SUPPRELIN® LA Support Center
  • After receiving the completed SRE and PAF, a Support Center representative will contact you and your healthcare professional's office to review the steps, process, and timeline needed to schedule the procedure

Offer good only in the USA and void where prohibited or otherwise restricted by law. Offer not valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other federal or state healthcare programs, including any state medical pharmaceutical assistance programs. Patients over the age of 18 are not eligible. Endo Pharmaceuticals Inc. has the right to rescind, revoke, or amend this program without notice. This offer is not transferable.

About SUPPRELIN® LA

Learn more about the only once-yearly CPP treatment that suppresses puberty-causing hormones through month 12 after the first month of therapy.

What Are My Child's
Treatment Options?

Find the CPP treatment that works with your child’s life.

Getting started with SUPPRELIN® Long-Acting

Endo, the maker of SUPPRELIN® LA, wants to make the process of getting treatment as simple as possible

A SUPPRELIN® LA Support Center representative will contact you after verifying your child's benefits and coverage details with your insurance company, including any necessary prior authorizations.

After your child is diagnosed with CPP, his or her health professional must send a required Service Request Enrollment Form (SRE) to the Support Center. This form serves as a “letter of medical necessity,“ which verifies that your child is eligible to receive the medicine.

You may be required to submit a signed Patient Authorization Form (PAF). Please contact the Support Center at 1-855-270-0123 to determine if this applies to you.

Download the Patient Authorization form

A representative may contact you regarding the SUPPRELIN® LA SHARES Program, which provides financial support to eligible patients.

The Support Center will determine whether SUPPRELIN® LA will be shipped directly to the hospital/medical center where the procedure will be performed or shipped through a specialty pharmacy.*

If a specialty pharmacy is involved, they will coordinate delivery of SUPPRELIN® LA to your hospital/medical center. Before shipping, the specialty pharmacy will contact you to review your financial responsibilities and discuss copay options.

A specialty pharmacy handles special types of medicines such as SUPPRELIN® LA. The Support Center will forward the SRE to the specialty pharmacy if necessary. It is very important that you return all phone calls from the specialty pharmacy as soon as possible because your child's treatment could be delayed if the specialty pharmacy has any questions.

After you schedule a date and time for the procedure with your child's healthcare professional or hospital/medical center, contact the Support Center to let them know the date of procedure.

Insertion & After-care

Learn more about the insertion and removal procedures for the SUPPRELIN® LA implant, after-care, and potential side effects.

Removal & Reinsertion

Learn more about removing the implant and inserting a new implant to continue treatment with SUPPRELIN® LA.

The SUPPRELIN® LA Support Center

We'll be with you every step of the way

Healthcare plans, insurance options, copays, and the process of reimbursement can be complex. The SUPPRELIN® LA Support Center offers you assistance as your child begins treatment. Your Support Center representative can help you arrange the services needed to begin therapy with SUPPRELIN® LA.

Your Support Center representative will work to help you understand your benefits
  • Assisting with verification of insurance coverage
  • Clarifying deductibles and copay for treatment and procedures
  • Providing information to eligible families about the SHARES Program,
    a financial support program
  • Answering general reimbursement questions
  • Coordinating the shipment of SUPPRELIN® LA directly to the procedure center identified by your child's healthcare professional

About SUPPRELIN® LA

Learn more about the only once-yearly CPP treatment that suppresses puberty-causing hormones through month 12 after the first month of therapy.

Watch One Girl's CPP Journey

A nurse—and mom—tells her daughter's CPP treatment story.

What is SUPPRELIN® LA?
  • SUPPRELIN® LA (histrelin acetate) is an under-the-skin (subcutaneous) implant that contains the medicine histrelin, a gonadotropin releasing hormone (GnRH). SUPPRELIN® LA is used for treatment of children with central precocious puberty (CPP)

  • CPP makes puberty come early in girls (before 8 years of age) and in boys (before 9 years of age). Signs of early puberty include breast enlargement in girls and the appearance of hair in the genital area in boys and girls. SUPPRELIN® LA works by reducing the amount of sex hormones in the blood to delay early puberty

  • Your child's doctor should do tests to make sure your child has CPP before treating your child with SUPPRELIN® LA

IMPORTANT SAFETY INFORMATION about SUPPRELIN® LA
  • Your child should not use SUPPRELIN® LA if he/she is allergic to gonadotropin releasing hormone (GnRH), GnRH agonist medicines, or anything in the SUPPRELIN® LA implant. Serious and life-threatening allergic reactions have happened with GnRH medicines (the type of medicine in SUPPRELIN® LA)

  • SUPPRELIN® LA should not be used in children under 2 years of age or in women who are or may become pregnant. SUPPRELIN® LA can cause birth defects or loss of the baby

  • In the first few weeks of treatment, SUPPRELIN® LA can cause a brief increase in some hormones, and during this time you may notice more signs of puberty in your child, including light vaginal bleeding and breast enlargement in girls. Within 4 weeks of treatment, you should see signs in your child that puberty is stopping

  • SUPPRELIN® LA is placed under the skin of the inside of the upper arm. The doctor will temporarily numb the arm of your child, make a small cut, and then place SUPPRELIN® LA under the skin. The cut may be closed with stitches or surgical strips and covered with a pressure bandage

  • Your child should keep the arm clean and dry and should not swim or bathe for 24 hours. The bandage can be removed after 24 hours. Do not remove any surgical strips. They will fall off on their own in several days. Your child should avoid heavy play or exercise that uses the implanted arm for 7 days. In rare cases, SUPPRELIN® LA may be ejected from the body through the insertion site, without your child noticing. You and your child should routinely check the insertion site until the cut is healed. After the cut has healed, your child can go back to his or her normal activities. The doctor will give you complete instructions

  • Keep all scheduled visits to the doctor. Your child's doctor will do regular exams and blood tests to check for signs of puberty. SUPPRELIN® LA lasts for 12 months. One implant provides the medicine for 12 months. After 12 months, SUPPRELIN® LA must be removed. The doctor may insert a new SUPPRELIN® LA at this time to continue treatment. Sometimes the doctor will have to do special examinations, such as ultrasound or MRI, if the SUPPRELIN® LA implant is difficult to find under your child's skin

  • The most common side effects of SUPPRELIN® LA are skin reactions at the place where the implant is inserted. Such reactions may include bruising, soreness, pain, tingling, itching, and swelling. They usually go away without treatment within 2 weeks. Call your child's doctor if your child has bleeding, redness or pain at the insertion site

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Labeling for SUPPRELIN® LA.

More Safety Info
What is SUPPRELIN® LA?
  • SUPPRELIN® LA (histrelin acetate) is an under-the-skin (subcutaneous) implant that contains the medicine histrelin, a gonadotropin releasing hormone (GnRH). SUPPRELIN® LA is used for treatment of children with central precocious puberty (CPP)

  • CPP makes puberty come early in girls (before 8 years of age) and in boys (before 9 years of age). Signs of early puberty include breast enlargement in girls and the appearance of hair in the genital area in boys and girls. SUPPRELIN® LA works by reducing the amount of sex hormones in the blood to delay early puberty

  • Your child's doctor should do tests to make sure your child has CPP before treating your child with SUPPRELIN® LA

IMPORTANT SAFETY INFORMATION about SUPPRELIN® LA
  • Your child should not use SUPPRELIN® LA if he/she is allergic to gonadotropin releasing hormone (GnRH), GnRH agonist medicines, or anything in the SUPPRELIN® LA implant. Serious and life-threatening allergic reactions have happened with GnRH medicines (the type of medicine in SUPPRELIN® LA)

  • SUPPRELIN® LA should not be used in children under 2 years of age or in women who are or may become pregnant. SUPPRELIN® LA can cause birth defects or loss of the baby

  • In the first few weeks of treatment, SUPPRELIN® LA can cause a brief increase in some hormones, and during this time you may notice more signs of puberty in your child, including light vaginal bleeding and breast enlargement in girls. Within 4 weeks of treatment, you should see signs in your child that puberty is stopping

  • SUPPRELIN® LA is placed under the skin of the inside of the upper arm. The doctor will temporarily numb the arm of your child, make a small cut, and then place SUPPRELIN® LA under the skin. The cut may be closed with stitches or surgical strips and covered with a pressure bandage

  • Your child should keep the arm clean and dry and should not swim or bathe for 24 hours. The bandage can be removed after 24 hours. Do not remove any surgical strips. They will fall off on their own in several days. Your child should avoid heavy play or exercise that uses the implanted arm for 7 days. In rare cases, SUPPRELIN® LA may be ejected from the body through the insertion site, without your child noticing. You and your child should routinely check the insertion site until the cut is healed. After the cut has healed, your child can go back to his or her normal activities. The doctor will give you complete instructions

  • Keep all scheduled visits to the doctor. Your child's doctor will do regular exams and blood tests to check for signs of puberty. SUPPRELIN® LA lasts for 12 months. One implant provides the medicine for 12 months. After 12 months, SUPPRELIN® LA must be removed. The doctor may insert a new SUPPRELIN® LA at this time to continue treatment. Sometimes the doctor will have to do special examinations, such as ultrasound or MRI, if the SUPPRELIN® LA implant is difficult to find under your child's skin

  • The most common side effects of SUPPRELIN® LA are skin reactions at the place where the implant is inserted. Such reactions may include bruising, soreness, pain, tingling, itching, and swelling. They usually go away without treatment within 2 weeks. Call your child's doctor if your child has bleeding, redness or pain at the insertion site

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Labeling for SUPPRELIN® LA.

Intended for U.S. Residents Only

Rx Only

SUPPRELIN® is a registered trademark of Endo International plc or one of its affiliates.

© 2016 Endo Pharmaceuticals Inc. All rights reserved. Malvern, PA 19355

  • Privacy/Legal
  • SP-05028/November 2016
  • www.supprelinla.com
  • 1-800-462-ENDO (3636)
What is SUPPRELIN® LA?
INDICATION & IMPORTANT SAFETY INFO
What is SUPPRELIN® LA?
  • SUPPRELIN® LA (histrelin acetate) is an under-the-skin (subcutaneous) implant that contains the medicine histrelin, a gonadotropin releasing hormone (GnRH). SUPPRELIN® LA is used for treatment of children with central precocious puberty (CPP)

  • CPP makes puberty come early in girls (before 8 years of age) and in boys (before 9 years of age). Signs of early puberty include breast enlargement in girls and the appearance of hair in the genital area in boys and girls. SUPPRELIN® LA works by reducing the amount of sex hormones in the blood to delay early puberty

  • Your child's doctor should do tests to make sure your child has CPP before treating your child with SUPPRELIN® LA

IMPORTANT SAFETY INFORMATION about SUPPRELIN® LA
  • Your child should not use SUPPRELIN® LA if he/she is allergic to gonadotropin releasing hormone (GnRH), GnRH agonist medicines, or anything in the SUPPRELIN® LA implant. Serious and life-threatening allergic reactions have happened with GnRH medicines (the type of medicine in SUPPRELIN® LA)

  • SUPPRELIN® LA should not be used in children under 2 years of age or in women who are or may become pregnant. SUPPRELIN® LA can cause birth defects or loss of the baby

  • In the first few weeks of treatment, SUPPRELIN® LA can cause a brief increase in some hormones, and during this time you may notice more signs of puberty in your child, including light vaginal bleeding and breast enlargement in girls. Within 4 weeks of treatment, you should see signs in your child that puberty is stopping

  • SUPPRELIN® LA is placed under the skin of the inside of the upper arm. The doctor will temporarily numb the arm of your child, make a small cut, and then place SUPPRELIN® LA under the skin. The cut may be closed with stitches or surgical strips and covered with a pressure bandage

  • Your child should keep the arm clean and dry and should not swim or bathe for 24 hours. The bandage can be removed after 24 hours. Do not remove any surgical strips. They will fall off on their own in several days. Your child should avoid heavy play or exercise that uses the implanted arm for 7 days. In rare cases, SUPPRELIN® LA may be ejected from the body through the insertion site, without your child noticing. You and your child should routinely check the insertion site until the cut is healed. After the cut has healed, your child can go back to his or her normal activities. The doctor will give you complete instructions

  • Keep all scheduled visits to the doctor. Your child's doctor will do regular exams and blood tests to check for signs of puberty. SUPPRELIN® LA lasts for 12 months. One implant provides the medicine for 12 months. After 12 months, SUPPRELIN® LA must be removed. The doctor may insert a new SUPPRELIN® LA at this time to continue treatment. Sometimes the doctor will have to do special examinations, such as ultrasound or MRI, if the SUPPRELIN® LA implant is difficult to find under your child's skin

  • The most common side effects of SUPPRELIN® LA are skin reactions at the place where the implant is inserted. Such reactions may include bruising, soreness, pain, tingling, itching, and swelling. They usually go away without treatment within 2 weeks. Call your child's doctor if your child has bleeding, redness or pain at the insertion site

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Labeling for SUPPRELIN® LA.